September 17 2021 5:21pm

COVID-19: FDA panel backs Pfizer booster only for 65+, high-risk Americans

An advisory committee for the U.S. Food and Drug Administration recommended giving booster shots for those aged 65 years and older, as well as those who run a high risk for severe disease. But the panel also shot down a plan to give the extra dose for most Americans aged 16 and older based on data they currently have.

Video Home